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Diabetic diarrhea and steatorrhea occur predominantly in young adult males who have
juvenile-onset diabetes mellitus complicated by neuropathy. The presentation is often severe,
with nocturnal or postprandial watery diarrhea and tenesmus. Massive malabsorption of fat
may occur; however, malabsorption of other nutrients and generalized wasting are quite rare.
Because the symptoms are relatively refractory to treatment, it is important to rule out other,
more easily treatable causes of this presentation. Bacterial overgrowth, exocrine pancreatic in-
sufficiency, and celiac disease are also associated with diabetes mellitus and can mimic this pro-
cess. Although the mechanism of diabetic diarrhea and steatorrhea remains unclear,
neuropathy, gastrointestinal motor abnormalities, bacterial overgrowth, and bile acid abnor-
malities have been implicated in the pathogenesis.
Diabetic diarrhea and steatorrhea, although rare manifestations of diabetes
mellitus, attain clinical importance because of their severity and refractory nature.
Despite extensive investigation, the pathogenesis of this disorder remains unclear.
In 1926, in their discussion of gastric secretion in the diabetic, Bowen and Aaron
[1] described ten patients with severe diarrhea. It was not until 1936, however, that
this problem was recognized as constituting a distinct clinical entity. At that time,
Bargen, Bollman, and Kepler [2] reported two cases of diabetic diarrhea that were
refractory to therapy with pancreatic extract, and that were, therefore, presumed to
be unrelated to pancreatic exocrine dysfunction. Since that time, direct measure-
ment has confirmed that pancreatic enzyme secretion is normal in patients with
diabetic diarrhea [3].
The association of this entity with the neuropathy of diabetes was recognized
early. In 1945, while reviewing the clinical manifestations of 125 diabetics with
neuropathy, Rundles [4] noticed the frequent occurrence of diarrhea, constipation,
alternating diarrhea and constipation, or crampy abdominal pain. Twenty-two per-
cent of the patients in that series had diarrhea.
The next year, Sheridan and Bailey [5] again recognized the clinical correlation of
gastrointestinal symptoms with neuropathy in the diabetic. They described 40 pa-
tients with a history of poor diabetic control and neuropathy who developed inter-
mittent nocturnal diarrhea with watery brown stools. Seventy-five percent of these
patients had nocturnal incontinence.
Steatorrhea was first recognized as another presentation of this entity by Berge et
al. [6] in 1956. The association with the neuropathy of diabetes persisted in this
series. These patients presented identically to those with diabetic diarrhea who had
normal fecal fat excretion. Bulky, malodorous stools were not seen, despite fecal fat
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levels as high as 70 g per day. Of note were the observations that these patients did
not lose weight or appear wasted, and the biochemical parameters that are typically
abnormal with malabsorption of other nutrients remained normal. The refractory
nature of this lesion was again recognized after unsuccessful therapeutic trials of
pancreatic enzymes, liver extract, anticholinergic agents, and corticosteroids.
This syndrome occurs in approximately one of every thousand diabetic patients
(reports range from 0.001 percent to seven percent). There is a marked male
predominance, despite the more frequent occurrence of diabetes in females than in
males. The typical age of onset is between 36 and 42 years, among people with a
history of prior diabetes for an average of eight years but with a range of a few
months to several decades. Most patients have juvenile-onset diabetes and require
insulin therapy.
The diarrhea is often severe, with up to fifty stools per day (typically ten to thirty),
occurring particularly at night or when the patient is lying down. There also may be
postprandial exacerbations. The character ofthe stool tends to be loose and watery,
brown in color, and often associated with tenesmus. Most patients have unpre-
dictable, intermittent symptoms. After a variable period of time, symptoms tend to
become less severe in those patients with continuous manifestations, and exacerba-
tions tend to become less severe and less frequent in patients with intermittent
manifestations. Again, weight loss and wasting are unusual in these patients.
The best clinical correlates with diabetic diarrhea and steatorrhea are the follow-
ing manifestations of diabetic neuropathy: orthostatic hypotension, impotence,
retrograde ejaculation, bladder incontinence, anhidrosis, night sweats, muscle
cramps, paresthesias, and loss of reflexes and vibratory sensation. Although other
complications of diabetes such as nephropathy and retinopathy may also be present,
these do not have a strong relationship with diarrhea.
DIFFERENTIAL DIAGNOSIS
In approaching the differential diagnosis of diarrhea in a diabetic patient, all of
the unrelated causes ofdiarrhea must be considered. A careful history is particularly
important to consider the osmotic diarrhea associated with ingestion of non-
absorbable hexitols. Diabetics can ingest large quantities of these in the form of
snacks. Differentiation between diarrhea and steatorrhea should also be made. This
may be done by performing a quantitative fecal fat determination on a timed sample
while the patient ingests a standard diet of 100 g fat. The presence of steatorrhea,
although completely compatible with this syndrome, might also be due to a more
readily treatable cause, such as pancreatic insufficiency. For this reason, the
presence of steatorrhea should lead to more extensive evaluation, possibly including
gastrointestinal X-rays, biochemical tests of absorption, and small bowel biopsy.
Abnormalities of pancreatic exocrine function, including decreased secretory
volume or enzyme output in response to stimulation by secretin or cholecystokinin,
have been reported in twenty to forty percent of diabetic patients [7]. However,
before pancreatic insufficiency can be held responsible for steatorrhea, enzyme
output needs to be reduced to less than ten percent of normal [8]. This degree of
pancreatic dysfunction has not been described in diabetes uncomplicated by pan-
creatitis. Conversely, diabetes mellitus is a common manifestation of chronic
pancreatitis with pancreatic insufficiency. A clinical history of excessive alcohol
intake or recurrent bouts of abdominal pain, or the presence of pancreatic calcifi-
cation on plain abdominal radiograph, warrants direct evaluation of pancreatic
exocrine function.
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Although the association of diabetes with celiac disease has been cited widely, the
reports have often been single case studies [9]. As the actual frequency of such cases
is low, the significance of the association remains unclear. There might be a com-
mon genetic predisposition for both, as the incidence of the histocompatibility anti-
gen HLA-B8 is higher than control levels (29 percent) in both celiac disease, where it
is 80 percent [10] and juvenile-onset diabetes, where it is 54 percent [11]. Although
the clinical presentations ofceliac disease and diabetic diarrhea may be quite similar,
there are differences which may serve as clues. Thephysician may suspect diarrhea is
not of diabetic origin if there is: (a) the history of gastrointestinal symptoms
preceding the diagnosis of diabetes, (b) the history of repeated episodes of
hypoglycemia, (c) the absence of neuropathy, (d) the presence of anemia, (e) low
serum folate concentration, (f) hypoalbuminemia, or (g) a malabsorption pattern
on small bowel radiograph. Small bowel biopsy should be performed. If villous
atrophy is present, a therapeutic trial of gluten-free diet is needed to document the
diagnosis of celiac disease. Gluten-free dietary therapy has never been helpful for
true diabetic diarrhea.
PATHOGENESIS
The pathogenesis of diabetic diarrhea remains obscure. Small intestinal mor-
phology has been found to be normal at the light microscopic and electron micro-
scopic levels [12,13]. The intestinal blood vessels show no evidence of micro-
angiopathy [13], and there are no morphologic changes typically associated with
intestinal ischemia.
The frequent clinical association with neuropathic findings may suggest a role for
damage to the autonomic nervous system in the pathogenesis. Diarrheacertainly can
occur with other processes affecting autonomic nervous function, such as vagot-
omy, sympathectomy, pheochromocytoma, and the administration of ganglionic
blocking agents. Uncontrollable diarrhea and steatorrhea were reported to be pres-
ent in a patient with amyloidosis involving the autonomic ganglia and myenteric
plexus, but not involving the intestinal mucosa [14].
The neuropathologic findings in diabetic diarrhea have been studied by Hensley
and Soergel [15]. They found two types of neural morphologic lesions associated
with diabetic diarrhea-a hydropic neural change producing "giant sympathetic
neurons" and the "dendritic swelling" of postganglionic neurons. The "giant sym-
pathetic neurons" were felt to represent a nonspecific form of degeneration that is
found also in alcoholic patients and in diabetic patients without diarrhea. The
"dendritic swelling" was a more consistent sign of visceral neuropathy, but also was
found in alcoholic patients and diabetic patients without diarrhea. Therefore, there
appears to be no characteristic, pathognomonic, morphologic, neural abnormality
in diabetic diarrhea. This certainly does not rule out a biochemical or functional
abnormality.
Such an abnormality has been suggested to be present at the level of the inter-
neural pathways in prevertebral and paravertebral sympathetic ganglia [3]. This
group [3] found normal intestinal motility responses to epinephrine, nor-
epinephrine, and methacholine in diabetics with diarrhea, which suggested normal
efferent sympathetic and parasympathetic pathways.
Neural abnormalities might produce diarrhea via a direct effect on motor func-
tion. Indeed, abnormal intestinal motility in diabetics has been suggested by
radiographic observations of gastric atony, segmentation and flocculation of the
barium column, and increased transit time [16]. Small bowel motility in diabetics
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with and without peripheral neuropathy and in those with and without diarrhea was
studied by McNally, Reinhard, and Schwartz [16]. They found onset of symptoms
of the peripheral neuropathy to be correlated with progressive decrease in upper
small bowel tone, as well as increase in frequency and amplitude of large peristaltic
waves. There were not sufficient patients with diabetic diarrhea in their group to
assess the role of motor disorders in the pathogenesis of this lesion.
Although slowed intestinal transit cannot be linked directly to the production of
diarrhea, it can be linked indirectly, mediated by resultant bacterial overgrowth.
Other disorders such as scleroderma, postgastrectomy steatorrhea, jejunal diver-
ticulosis, and blind loop syndrome which have abnormal bowel motility can have
associated bacterial overgrowth and malabsorption. The role of intestinal bacteria in
the pathogenesis of diabetic diarrhea was suggested by Malins and French [17], who
observed dramatic improvement in several patients treated with a broad spectrum
antibiotic. However, the unpredictable course of diabetic diarrhea makes this obser-
vation difficult to interpret. Green, Berge, and Sprague [18] performed a double-
blind study to evaluate the efficacy of antibiotic therapy for diabetic diarrhea and
found that some patients had symptoms which improved with antibiotics and which
recurred on placebo. Although not all patients responded, enough did to warrant a
therapeutic trial. These observations were confirmed by Goldstein, Wirts, and
Kowlessar [19] who also cultured upper gastrointestinal aspirates. Their work also
confirmed the lack of bacterial overgrowth in the majority of patients with diabetic
diarrhea. The 14C-glycocholate breath test can be used to predict which diabetics
have bacterial overgrowth and would benefit from antibiotic therapy [20].
Bile acid abnormalities have also been thought to play a role in the pathogenesis
of diabetic diarrhea [21]. Molloy and Tomkin [21] have found that diabetics with
neuropathy have an enlarged bile salt pool with increased dihydroxy bile salts and
increased fecal bile salt excretion compared to normal controls. The diabetics with
diarrhea developed a smaller bile salt pool. This was interpreted to suggest an inter-
mittent cholereic enteropathy. However, other authors have not confirmed the in-
crease in fecal bile salt excretion in diabetics with diarrhea [20], and cholestyramine,
a bile salt-binding resin, has not helped the majority of patients.
TREATMENT
Treatment of diabetic diarrhea is often not effective. Therapeutic trials have been
difficult to interpret due to the intermittent and unpredictable clinical course of this
disorder. An important phase of treatment is making sure a treatable cause of
diarrhea is not being missed.
Careful diabetic control is recommended, based on the observations that some
forms of diabetic neuropathy are reversible and that some recurrences of
gastrointestinal symptoms have been associated with prolonged periods of poor
diabetic control. There is no evidence, however, that good control of the diabetes
willimprove the diarrhea. There is a recent report that hypoglycemia may contribute
to the gastrointestinal manifestations, and that a reduction of insulin dose has a
beneficial effect on some patients [22].
As mentioned above, a therapeutic trial of antibiotics is worthwhile, although
many patients do not improve on this regimen. The type of antibiotic and dosage
regimen have not been critically evaluated. Tetracycline has been effective with an
initial dose of 1 g daily, tapered to 250 mg daily as a maintenance or intermittent
dose.
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Most therapy is symptomatic, using antidiarrheal agents such as diphenoxylate
hydrochloride or psyllium hydrophilic mucilloid powder.
CONCLUSIONS
Diabetic diarrhea and steatorrhea can be a severe complication of diabetes
mellitus, one which can be extremely debilitating and refractory to therapy. The
mechanism ofthis remains unclear, although neuropathy, gastrointestinal motor ab-
normalities, bacterial overgrowth, and bile acid abnormalities have been implicated
in the pathogenesis. It is particularly important to rule out other, moreeasily treated
causes of this presentation in diabetic patients, before attempting symptomatic
therapy.
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